Palantir (PLTR) 10-Q 12 Aug 21 2021 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2021	Aug. 05, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	Palantir Technologies Inc.
Entity Central Index Key	0001321655
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Incorporation, State or Country Code	DE
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	PLTR
Security Exchange Name	NYSE
Entity File Number	001-39540
Entity Address, Address Line One	1555 Blake Street, Suite 250
Entity Address, Postal Zip Code	80202
Entity Tax Identification Number	68-0551851
City Area Code	720
Local Phone Number	358-3679
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,866,000,060
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		86,117,515
Common Class F [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,005,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents		$ 2,341,156	$ 2,011,323
Restricted cash		36,750	37,285
Accounts receivable		242,998	156,932
Prepaid expenses and other current assets		41,648	51,889
Total current assets		2,662,552	2,257,429
Property and equipment, net		24,824	29,541
Restricted cash, noncurrent		61,914	79,538
Operating lease right-of-use assets		209,243	217,075
Other assets		117,135	106,921
Total assets		3,075,668	2,690,504
Current liabilities:
Accounts payable		30,914	16,358
Accrued liabilities		166,252	158,546
Deferred revenue	[1]	194,511	189,520
Customer deposits		257,747	210,320
Operating lease liabilities		33,162	29,079
Total current liabilities		682,586	603,823
Deferred revenue, noncurrent	[1]	40,518	50,525
Customer deposits, noncurrent		62,732	81,513
Debt, noncurrent, net			197,977
Operating lease liabilities, noncurrent		216,630	229,800
Other noncurrent liabilities		4,239	4,316
Total liabilities		1,006,705	1,167,954
Commitments and Contingencies (Note 8)
Stockholders' equity (deficit):
Preferred stock, par value $0.001: 2,000,000 shares authorized and 0 issued and outstanding as of June 30, 2021 and December 31, 2020		0	0
Common stock		1,937	1,792
Additional paid-in capital		7,294,369	6,488,857
Accumulated other comprehensive income (loss)		65	(2,745)
Accumulated deficit		(5,227,408)	(4,965,354)
Total stockholders' equity		2,068,963	1,522,550
Total liabilities and stockholders' equity		$ 3,075,668	$ 2,690,504
[1]	Deferred revenue as of June 30, 2021 and December 31, 2020 includes $53.2 million and $68.2 million, respectively, from Palantir Technologies Japan, K.K. See Note 6. Equity Method Investments, for more information.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000,000,000	2,000,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	22,701,005,000	22,701,005,000
Common stock, shares issued	1,936,578,000	1,792,140,000
Common stock, shares outstanding	1,936,578,000	1,792,140,000
Palantir Technologies Japan, K.K. [Member]
Deferred revenue	$ 53.2	$ 68.2
Class A Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	20,000,000,000	20,000,000,000
Common stock, shares issued	1,855,143,000	1,542,058,000
Common stock, shares outstanding	1,855,143,000	1,542,058,000
Class B Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	2,700,000,000	2,700,000,000
Common stock, shares issued	80,430,000	249,077,000
Common stock, shares outstanding	80,430,000	249,077,000
Class F Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,005,000	1,005,000
Common stock, shares issued	1,005,000	1,005,000
Common stock, shares outstanding	1,005,000	1,005,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenue	$ 375,642	$ 251,889	$ 716,876	$ 481,216
Cost of revenue	90,926	68,410	165,037	132,704
Gross profit	284,716	183,479	551,839	348,512
Operating expenses:
Sales and marketing	162,379	102,518	298,476	201,171
Research and development	110,524	86,815	208,995	152,615
General and administrative	157,961	93,291	304,530	164,056
Total operating expenses	430,864	282,624	812,001	517,842
Loss from operations	(146,148)	(99,145)	(260,162)	(169,330)
Interest income	372	551	748	3,818
Interest expense	(590)	(5,646)	(2,430)	(10,240)
Change in fair value of warrants		(3,683)	0	10,012
Other income (expense), net	2,125	(1,589)	(2,769)	4,511
Loss before provision (benefit) for income taxes	(144,241)	(109,512)	(264,613)	(161,229)
Provision (benefit) for income taxes	(5,661)	943	(2,559)	3,500
Net loss	$ (138,580)	$ (110,455)	$ (262,054)	$ (164,729)
Net loss per share attributable to common stockholders, basic	$ (0.07)	$ (0.17)	$ (0.14)	$ (0.27)
Net loss per share attributable to common stockholders, diluted	$ (0.07)	$ (0.17)	$ (0.14)	$ (0.28)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic	1,894,606	640,450	1,858,085	616,150
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted	1,894,606	640,669	1,858,085	618,635

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (138,580)	$ (110,455)	$ (262,054)	$ (164,729)
Other comprehensive income:
Foreign currency translation adjustments	(800)	577	2,810	1,603
Comprehensive loss	$ (139,380)	$ (109,878)	$ (259,244)	$ (163,126)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock [Member]	Common Stock [Member]Series H-1 Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]Series H-1 Convertible Preferred Stock [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Redeemable Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series H-1 Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series K Convertible Preferred Stock [Member]
Temporary equity, beginning period, Shares at Dec. 31, 2019									4,017,000	742,840,000
Temporary equity, beginning period at Dec. 31, 2019									$ 33,569	$ 2,093,662
Balance at beginning period, Shares at Dec. 31, 2019		581,497,000				6,393,000
Balance at beginning period at Dec. 31, 2019	$ (1,980,642)	$ 588		$ 1,857,331		$ (38,895)	$ (703)	$ (3,798,963)
Conversion of convertible preferred stock to common stock, Shares			28,000								(28,000)
Conversion of convertible preferred stock to common stock	100				$ 100						$ (100)
Issuance of Series K redeemable convertible preferred stock upon exercise of warrants, Shares												121,000
Issuance of Series K redeemable convertible preferred stock upon exercise of warrants												$ 947
Repurchase of common stock, held in treasury, Shares		(808,000)				808,000
Repurchase of common stock, held in treasury	(3,777)					$ (3,777)
Issuance of common stock from the exercise of stock options	28,824	$ 38		28,786
Issuance of common stock from the exercise of stock options, Shares		37,697,000
Issuance of common stock upon net exercise of common stock warrants, Shares		118,221,000
Issuance of common stock upon net exercise of common stock warrants	537,849	$ 118		537,731
Retirement of treasury stock, Shares						(7,201,000)
Retirement of treasury stock		$ (7)		(42,665)		$ 42,672
Stock-based compensation	182,071			182,071
Other comprehensive income (loss)	1,603						1,603
Net loss	(164,729)							(164,729)
Balance at end of period, Shares at Jun. 30, 2020		736,635,000
Balance at end of period at Jun. 30, 2020	(1,398,701)	$ 737		2,563,354			900	(3,963,692)
Temporary equity, ending period, Shares at Jun. 30, 2020									4,017,000	742,933,000
Temporary equity, ending period at Jun. 30, 2020									$ 33,569	$ 2,094,509
Temporary equity, beginning period, Shares at Mar. 31, 2020									4,017,000	742,812,000
Temporary equity, beginning period at Mar. 31, 2020									$ 33,569	$ 2,093,562
Balance at beginning period, Shares at Mar. 31, 2020		588,033,000				7,201,000
Balance at beginning period at Mar. 31, 2020	(1,976,619)	$ 595		1,918,372		$ (42,672)	323	(3,853,237)
Issuance of Series K redeemable convertible preferred stock upon exercise of warrants, Shares												121,000
Issuance of Series K redeemable convertible preferred stock upon exercise of warrants												$ 947
Issuance of common stock from the exercise of stock options	22,114	$ 31		22,083
Issuance of common stock from the exercise of stock options, Shares		30,381,000
Issuance of common stock upon net exercise of common stock warrants, Shares		118,221,000
Issuance of common stock upon net exercise of common stock warrants	537,849	$ 118		537,731
Retirement of treasury stock, Shares						(7,201,000)
Retirement of treasury stock		$ (7)		(42,665)		$ 42,672
Stock-based compensation	127,833			127,833
Other comprehensive income (loss)	577						577
Net loss	(110,455)							(110,455)
Balance at end of period, Shares at Jun. 30, 2020		736,635,000
Balance at end of period at Jun. 30, 2020	(1,398,701)	$ 737		2,563,354			900	(3,963,692)
Temporary equity, ending period, Shares at Jun. 30, 2020									4,017,000	742,933,000
Temporary equity, ending period at Jun. 30, 2020									$ 33,569	$ 2,094,509
Balance at beginning period, Shares at Dec. 31, 2020		1,792,140,000
Balance at beginning period at Dec. 31, 2020	1,522,550	$ 1,792		6,488,857			(2,745)	(4,965,354)
Issuance of common stock from the exercise of stock options	$ 376,688	$ 114		376,574				0
Issuance of common stock from the exercise of stock options, Shares	114,471,000	114,471,000
Issuance of common stock upon vesting of RSUs, Shares		23,832,000
Issuance of common stock upon vesting of RSUs		$ 24		(24)
Issuance of common stock upon vesting of growth units, Shares		1,471,000
Issuance of common stock upon vesting of growth units		$ 1		(1)
Issuance of common stock upon net exercise of common stock warrants and other	$ 1,712	$ 6		1,706
Issuance of common stock upon net exercise of common stock warrants and other, Shares		4,664,000
Stock-based compensation	427,257			427,257
Other comprehensive income (loss)	2,810						2,810
Net loss	(262,054)							(262,054)
Balance at end of period, Shares at Jun. 30, 2021		1,936,578,000
Balance at end of period at Jun. 30, 2021	2,068,963	$ 1,937		7,294,369			65	(5,227,408)
Balance at beginning period, Shares at Mar. 31, 2021		1,860,607,000
Balance at beginning period at Mar. 31, 2021	1,805,943	$ 1,860		6,892,046			865	(5,088,828)
Issuance of common stock from the exercise of stock options	167,828	$ 59		167,769
Issuance of common stock from the exercise of stock options, Shares		59,171,000
Issuance of common stock upon vesting of RSUs, Shares		12,872,000
Issuance of common stock upon vesting of RSUs		$ 13		(13)
Issuance of common stock upon net exercise of common stock warrants and other	1,712	$ 5		1,707
Issuance of common stock upon net exercise of common stock warrants and other, Shares		3,928,000
Stock-based compensation	232,860			232,860
Other comprehensive income (loss)	(800)						(800)
Net loss	(138,580)							(138,580)
Balance at end of period, Shares at Jun. 30, 2021		1,936,578,000
Balance at end of period at Jun. 30, 2021	$ 2,068,963	$ 1,937		$ 7,294,369			$ 65	$ (5,227,408)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Operating activities
Net loss	$ (262,054)	$ (164,729)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	7,999	7,793
Stock-based compensation	426,473	181,955
Change in fair value of warrants	0	(10,012)
Non-cash operating lease expense	14,435	19,831
Other operating activities	560	3,633
Changes in operating assets and liabilities:
Accounts receivable	(83,883)	(56,583)
Prepaid expenses and other current assets	12,770	(3,220)
Other assets	(9,522)	(9,937)
Accounts payable	14,589	(35,012)
Accrued liabilities	9,070	(30,366)
Deferred revenue, current and noncurrent	(3,679)	19,645
Customer deposits, current and noncurrent	28,668	(124,434)
Operating lease liabilities, current and noncurrent	(15,795)	(25,815)
Other noncurrent liabilities	0	921
Net cash used in operating activities	139,631	(226,330)
Investing activities
Purchases of property and equipment	(1,405)	(5,945)
Proceeds from the sale of assets held for sale	0	250
Net cash used in investing activities	(1,405)	(5,695)
Financing activities
Proceeds from the issuance of common stock, net of issuance costs	0	542,922
Proceeds from issuance of debt, net of issuance costs	0	149,683
Principal payments on borrowings	(200,000)	(250,000)
Proceeds from the exercise of common stock options	376,688	28,824
Repurchase of common stock	0	(3,777)
Other financing activities	(1,744)	(377)
Net cash provided by (used in) financing activities	174,944	467,275
Effect of foreign exchange on cash, cash equivalents, and restricted cash	(1,496)	(197)
Net increase in cash, cash equivalents, and restricted cash	311,674	235,053
Cash, cash equivalents, and restricted cash - beginning of period	2,128,146	1,401,962
Cash, cash equivalents, and restricted cash - end of period	2,439,820	1,637,015
Supplemental disclosures of cash flow information:
Cash paid for income taxes	3,425	8,144
Cash paid for interest	2,381	5,644
Supplemental disclosures of non-cash investing and financing information:
Common stock issuance costs included in accounts payable and accrued liabilities	$ 0	$ 5,072

Organization

Organization	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	1. Organization Palantir Technologies Inc. (including its subsidiaries, “Palantir,” or “the Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms, Palantir Gotham and Palantir Foundry, that serve as the central operating systems for its customers.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. genera l ly accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminat e o The unaudited condensed consolidated balance sheet as of December 31, 2020 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”) 2016-02, These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, collectability of accounts receivable, useful lives of tangible assets, and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2. Significant Accounting Policies 10-K ended June 30, 2021. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of June 30, 2021 2020 Cash and cash equivalents $ 2,341,156 $ 1,497,591 Restricted cash 36,750 37,069 Restricted cash, noncurrent 61,914 102,355 Total cash, cash equivalents, and restricted cash $ 2,439,820 $ 1,637,015 Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants non-collateralized COVID-19 written-off expected to be material. Concentrations of Credit Risk and Other Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of June 30, 2021 and December 31, 2020 were $243.0 million and $156.9 million, respectively. Customer I represented 24% of total accounts receivable as of June 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of June 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of June 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable. For the three and six months ended June 30, 2021, no customer represented more than 10% of total revenue. For the three and six months ended June 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue and Customer A, which is in the commercial operating segment, represented 10% of total revenue, respectively. No other customer represented more than 10% of total revenue for the three and six months ended June 30, 2020. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service functions of its business. Recently Adopted Accounting Pronouncements I 2019-12, Simplifying the Accounting for Income Taxes (Topic 740) as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements.

Contract Liabilities and Remain

Contract Liabilities and Remaining Performance Obligations	6 Months Ended
	Jun. 30, 2021
Revenue from Contract with Customer [Abstract]
Contract Liabilities and Remaining Performance Obligations	3. Contract Liabilities and Remaining Performance Obligations Contract Liabilities The Company’s contract liabilities consist of deferred revenue and customer deposits. As of June 30, 2021 and December 31, 2020, the Company’s contract liability balances were $555.5 million and $531.9 million, respectively. Revenue of $285.4 million and $301.3 million was recognized during the six months ended June 30, 2021 and 2020, respectively, that was included in the contract liability balances as of December 31, 2020 and 2019, respectively. Remaining Performance Obligations The Company’s arrangements with its customers oft e The Company’s remaining performance obligations were $671.9 million as of June 30, 2021, of which the Company expects to recognize approximately 49% as revenue over the next twelve months. Disaggregation of Revenue See Note 13. Segment and Geographic Information

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	4. Fair Value Measurements Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, other assets accounted for at fair value, accounts payable, and accrued liabilities. money market funds and certificates of deposit are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. The following tables present the Company’s assets that are measured at fair value on a recurring and nonrecurring basis and indicates the fair value hierarchy of the valuation (in thousands): As of June 30, 2021 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 963,873 $ 963,873 $ — $ — Certificates of deposit 65,477 — 65,477 — Total $ 1,029,350 $ 963,873 $ 65,477 $ — As of December 31, 2020 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 1,075,783 $ 1,075,783 $ — $ — Certificates of deposit 74,097 — 74,097 — Total $ 1,149,880 $ 1,075,783 $ 74,097 $ — Certificates of Deposit The Company’s Level 2 instruments consist of restricted cash invested in certificates of deposit. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Gross unrealized gains or losses for cash equivalents as of June 30, 2021 and December 31, 2020 were not material.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components	5. Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of June 30, 2021 As of December 31, Leasehold improvements $ 81,057 $ 85,196 Computer equipment, software, and other 23,199 22,275 Furniture and fixtures 10,069 9,976 Construction in progress 442 493 Total property and equipment, gross 114,767 117,940 Less: accumulated depreciation and amortization (89,943) (88,399) Total property and equipment, net $ 24,824 $ 29,541 Depreciation and amortization expense related to property and equipment, net was $3.1 million and $3.2 million for the three months ended June 30, 2021 and 2020, respectively, and $6.3 million and $6.8 million for the s i Accrued Liabilities Accrued liabilities consisted of the following (in thousands): As of June 30, As of December 31, Accrued payroll and related expenses $ 95,574 $ 85,466 Accrued other liabilities 70,678 73,080 Total accrued liabilitie s $ 166,252 $ 158,546

Equity Method Investments

Equity Method Investments	6 Months Ended
	Jun. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	6. Equity Method Investments Palantir Technologies Japan, K.K. During November 2019, the Company and SOMPO Holdings, Inc. (“SOMPO”) created a Japanese Kabushiki Kaisha (“K.K.”), Palantir Technologies Japan, K.K. (“Palantir Japan”), to distribute Palantir platforms to the Japanese market. Upon closing of the transaction with SOMPO, the Company purchased a total of 100,000 shares of Palantir Japan common stock for $25.0 million. The shares the Company received in exchange represent a 50% voting interest in Palantir Japan. The remaining 50% of the voting interest is held by SOMPO. The Company’s investment in Palantir Japan is accounted for as an equity method investment as the Company is able to exercise significant influence over, but does not control, the investee.

Debt

Debt	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Debt	7. Debt 2014 Credit Facility In October 2014, the Company entered into an unsecured revolving credit facility which has been subsequently amended (the “2014 Credit Facility”). The 2014 Credit Facility incurred interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% per annum, subject to certain adjustments, and incurs a commitment fee of 0.375% assessed on the daily average undrawn p o During April 2021, the Company entered into an amendment to the 2014 Credit Facility, which provided for an increase of $200.0 million to the revolving commitments of the existing lenders under the 2014 Credit Facility, for total revolving commitments of $400.0 million, and which also provided for an incremental loan facility for additional loans in an agg r The 2014 Credit Facility contains customary representations and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of June 30, 2021.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies Purchase Commitments In December 2019, the Company entered into, and subsequently amended during December 2020, a minimum annual commitment to purchase cloud hosting services of at least $1.49 billion over six contract years, with an optional carryover period through June 30, 2029, in exchange for various discounts on such services. If the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract. The Company satisfied its $126.0 million commitment for the contract year ended June 30, 2021. The commitment amount for the contract year ended June 30, 2022 is In June 2020, the Company entered into an additional commitment to purchase at least $45.0 million of cloud hosting services over a period of five years commencing on June 1, 2020 and ending on May 31, 2025. If the spend commitment is not met at the end of the term, the Company is obligated to pay the full amount of the outstanding balance (“shortfall payment”). The shortfall payment may be applied as a prepayment against consumption during an additional twelve-month coverage period expiring on May 31, 2026, at which time any unused amount would be forfeited. As of June 30, 2021, the Company had satisfied $6.0 million of its commitment. Investment Commitments The Company approved and entered into certain agreements (“Investment Agreements”) to purchase, or commit to purchase, shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, or commitments to purchase, the “Investments”). As of June 30, 2021, the Company had outstanding commitments, subject to the applicable terms and conditions, to purchase a total of 25.0 million shares for an aggregate purchase price of million. The closings of certain of such Investments are contingent upon the completion of a proposed business combination between the applicable Investee and other applicable parties. As of June 30, 2021, none of such Investments had closed. Additionally, in connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services. The maximum potential revenue from these commercial contracts is $428 million, which is inclusive of $73 million from contractual options, and the terms of such contracts, including these contractual options, range from three ten years . The majority of these commercial contracts are subject to various termination provisions, including for convenience in the event a proposed business combination is not completed. The Company assessed the concurrent agreements under the non-monetary - Revenue from Contracts with Customers such $3.0 million. The following table presents details related to the Company’s investment commitments as of June 30, 2021 (in thousands): Entity Investment Committed Committed Lilium March 30, 2021 4,100 $ 41,000 Sarcos Robotics (1) April 5, 2021 2,100 21,000 Roivant Sciences May 1, 2021 3,000 30,000 Celularity (1)(2) May 5, 2021 2,000 20,000 Mobility company May 11, 2021 2,000 20,000 Wejo May 28, 2021 3,500 35,000 Babylon Health (1) June 3, 2021 3,500 35,000 Boxed (1) June 13, 2021 2,000 20,000 Pear Therapeutics June 21, 2021 1,000 10,000 Autonomous vehicle company (1) June 22, 2021 1,800 18,000 Total 25,000 $ 250,000 (1) Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. (2) The Company’s investment closed during July 2021. Litigation and Legal Proceedings From time to time, third parties may assert paten t . On December 14, 2017, members of KT4 Partners LLC (Managing Member Marc Abramowitz) and Sandra Martin Clark, as trustee for the Marc Abramowitz Irrevocable Trust Number 7 (together, “KT4 Plaintiffs”), filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with a potential sale of stock by the KT4 Plaintiffs to a third party. The KT4 Plaintiffs seek compensatory and punitive damages, interest, fees, and costs . The Company believes this lawsuit is without merit and is vigorously defending itself against it. Given the uncertainty of litigation, it may be reasonably possible that the Company will incur a loss with regards to the matter; however, it cannot currently estimate a range of possible losses. Accordingly, the Company is unable, at this time, to estimate the overall effects that may result from the lawsuit on its financial condition, results of operations, or cash flows. As of June 30, 2021, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that were expected to have a material adverse impact on its condensed consolidated financial statements. Letters of Credit and Guarantees The Company had irrevocable standby letters of credit and guarantees, including bank guarantees, outstanding in the amounts of $98.7 million and $116.8 million as of June 30, 2021 and December 31, 2020, respectively, all of which were fully collateralized. The Company is required to maintain these letters of credit and guarantees primarily for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. As of June 30, 2021, these letters of credit and guarantees had expiration dates through August 2028. Warranties and Indemnification The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations via its operations and maintenance (“O&M”) services to its customers. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer; and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision, as set forth in the applicable SLA, or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of June 30, 2021 and December 31, 2020. The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of June 30, 2021 and December 31, 2020. The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s bylaws and Amended and Restated Certificate of Incorporation .

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2021
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure	9. Stockholders’ Equity The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described below and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel ( the Holders of common stock are entitled to dividends when, as and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of June 30, 2021. In connection with the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“Direct Listing”) in September 2020, all outstanding shares of redeemable convertible preferred stock and convertible preferred stock were converted into 4,017,378 and 793,725,807 shares of Class B common stock, respectively, and 1,005,000 shares of Class B common stock held by the Founders were exchanged for an equal number of shares of Class F common stock. The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of June 30, 2021 As of December 31, 2020 Authorized Issued and Authorized Issued and Common stock: Class A 20,000,000 1,855,143 20,000,000 1,542,058 Class B 2,700,000 80,430 2,700,000 249,077 Class F 1,005 1,005 1,005 1,005 Total 22,701,005 1,936,578 22,701,005 1,792,140

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	10. Stock-Based Compensation Stock Options The following table summarizes stock option activity for the six months ended June 30, 2021 (in thousands, except per share amounts): Options Weighted- Weighted- Remaining Aggregate Balance as of December 31, 2020 535,767 $ 6.12 7.99 $ 9,340,245 Options exercised (114,471 ) 3.29 Options canceled and forfeited (3,622 ) 5.17 Balance as of June 30, 2021 417,674 $ 6.90 8.49 $ 8,128,222 Options vested and exercisable as of June 30, 2021 213,423 $ 3.92 6.41 $ 4,788,520 As of June 30, 2021, the unrecognized expense related to options outstanding was $1.0 billion, which is expected to be recognized over a weighted-average service period of 8.07 years. RSUs The following table summarizes the RSU activity for the six months ended June 30, 2021 (in thousands, except per share amounts): RSUs Weighted Average Unvested and outstanding as of December 31, 2020 184,870 $ 6.97 RSUs granted 10,131 27.25 RSUs vested (23,832 ) 8.41 RSUs canceled (4,447 ) 7.21 Unvested and outstanding as of June 30, 2021 166,722 $ 7.98 As of June 30, 2021, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $815.0 million, which the Company expects to recognize over 3.20 years. Growth Units In May 2019, the Company granted growth units which vest upon the satisfaction of both a performance-based vesting condition, which was satisfied upon the Company’s Direct Listing, and a service-based vesting condition, which was satisfied in March 2021. In March 2021, the 3.6 million outstanding growth units vested and, per the formula applicable to the awards, converted into 1.5 million shares of common stock. During the three months ended March 31, 2021, the Company recognized the remaining stock-based compensation expense related to the growth units of $1.2 million. Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Cost of revenue $ 24,029 $ 17,832 $ 40,006 $ 25,900 Sales and marketing 72,008 39,932 129,294 58,395 Research and development 50,630 37,897 88,504 52,929 General and administrative 86,075 32,187 168,669 44,731 Total stock-based compensation expense $ $ $ $

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	11. Income Taxes The Company recorded a benefit for income taxes of million for the three months ended June 30, 2021 and 2020, respectively, and a benefit for income taxes of million and a provision for income taxes of million for the six months ended June 30, 2021 and 2020, respectively. The Company is subject to income tax in the U.S. as well as other tax jurisdictions in which it conducts business. The Company’s effective rate differs from the U.S. statutory rate primarily due to the valuation allowance recorded on its losses from the U.S. and other jurisdictions, foreign income taxed at different rates, non-deductible of stock-based compensation and the revaluation of its United Kingdom (“UK”) deferred tax assets as a result of a change in the UK corporate tax rate enacted during the current quarter, which increase d The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company assesses its ability to realize the deferred tax assets on a quarterly basis, and it establishes a valuation allowance if it is more-likely-than-not allowance deferred tax assets.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	12. Net Loss Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended Six Months Ended 2021 2020 2021 2020 Numerator Net loss attributable to common stockholders $ (138,580 ) $ (110,455 ) $ (262,054 ) $ (164,729 ) Less: Change in fair value attributable to participating securities — (171 ) — (7,479 ) Net loss attributable to common stockholders, for diluted net loss per share $ (138,580 ) $ (110,626 ) $ (262,054 ) $ (172,208 ) Denominator Weighted-average shares used in computing net loss per share, basic 1,894,606 640,450 1,858,085 616,150 Weighted-average shares used in computing net loss per share, diluted 1,894,606 640,669 1,858,085 618,635 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.07 ) $ (0.17 ) $ (0.14 ) $ (0.27 ) Net loss per share attributable to common stockholders, diluted $ (0.07 ) $ (0.17 ) $ (0.14 ) $ (0.28 ) The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Redeemable convertible preferred stock — 4,017 — 4,017 Convertible preferred stock — 791,346 — 791,346 Warrants to purchase redeemable convertible and convertible preferred — 20,839 — 18,253 Warrants to purchase common stock 13,042 — 13,042 — Options and SARs issued and outstanding 417,699 459,239 417,699 459,239 RSUs outstanding 166,722 178,685 166,722 178,685 Growth units outstanding — 3,583 — 3,583 Total 597,463 1,457,709 597,463 1,455,123

Segment and Geographic Informat

Segment and Geographic Information	6 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Segment and Geographic Information	13. Segment and Geographic Information The following tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the chief operating decision maker (“CODM”) evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented. Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development expenses, and general and administrative expenses. Financial information for each reportable segment was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: Government $ 232,119 $ 139,569 $ 440,539 $ 257,696 Commercial 143,523 112,320 276,337 223,520 Total revenue $ 375,642 $ 251,889 $ 716,876 $ 481,216 Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Contribution: Government $ 143,253 $ 80,327 $ 274,999 $ 132,224 Commercial 75,121 58,398 147,664 99,412 Total contribution $ 218,374 $ 138,725 $ 422,663 $ 231,636 The reconciliation of contribution to loss from operations is as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Loss from operations $ (146,148 ) $ (99,145 ) $ (260,162 ) $ (169,330 ) Research and development expenses (1) 59,894 48,918 120,491 99,686 General and administrative expenses (1) 71,886 61,104 135,861 119,325 Stock-based compensation expense 232,742 127,848 426,473 181,955 Total contribution $ 218,374 $ 138,725 $ 422,663 $ 231,636 ————— (1) Geographic Information Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended June 30, 2021 2020 Amount % Amount % Revenue: United States $ 199,930 53 % 124,993 50 % United Kingdom 39,935 11 % 30,033 12 % France 19,088 5 % 29,629 12 % Rest of world (1) 116,689 31 % 67,234 26 % Total revenue $ 375,642 % 251,889 100 % (1) 10 % or more of total revenue for the three months ended June 30, 2021 or 2020. Six Months Ended June 30, 2021 2020 Amount % Amount % Revenue: United States $ 398,377 56% $ 234,770 49% United Kingdom 74,320 10% 59,008 12% France 40,178 6% 55,359 12% Rest of world (1) 204,001 28% 132,079 27% Total revenue $ 716,876 100% $ 481,216 100% (1)

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events Investment Commitments and Investments The Company approved and entered into additional Investment Agreements from July 1, 202 6.0 million shares for an aggregate purchase price of $ 60.0 million. The closings of certain of such Investments are contingent upon the completion of a proposed business combination between the applicable Investee and other applicable parties. The following table presents details regarding such additional investment commitments outstanding as of the date of this filing (in thousands): Entity Investment Agreement Committed Committed Fast Radius (1) July 18, 2021 2,000 $ 20,000 Tritium (1) July 27, 2021 1,500 15,000 AdTheorent (1) July 27, 2021 1,500 15,000 FinAccel August 2, 2021 1,000 10,000 Total 6,000 $ 60,000 (1) onvenience . Additionally, during July 1, 2021 through the date of this filing, the Company purchased million shares for an aggregate purchase price of $ million, as set forth in the following table (in thousands): Entity Share Amount Investment Amount Celularity (1) 2,000 $ 20,000 Electric vehicle company 2,500 25,000 Autonomous aerial vehicle company 3,000 3,000 Astrocast 1,518 5,000 Total 9,018 $ 53,000 (1) Footnote 8. Commitments and Contingencies . In connection with the signing of the Investment Agreements entered into between July 1, 2021 and the date of this filing, each Investee or an associated entity and the Company million, and the terms of such contracts rang The majority of these commercial contracts are subject to various termination provisions, including for convenience in the event a proposed business combination is not completed. Investment in Gold During August 2021, the Company purchased $50.7 million in 100-ounce gold bars. Such purchase will initially be kept in a secure third-party facility located in the northeastern United States and the Company is able to take physical possession of the gold bars stored at the facility at any time with reasonable notice.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. genera l ly accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminat e o The unaudited condensed consolidated balance sheet as of December 31, 2020 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”) 2016-02, These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, collectability of accounts receivable, useful lives of tangible assets, and the incremental borrowing rate for operating leases. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of June 30, 2021 2020 Cash and cash equivalents $ 2,341,156 $ 1,497,591 Restricted cash 36,750 37,069 Restricted cash, noncurrent 61,914 102,355 Total cash, cash equivalents, and restricted cash $ 2,439,820 $ 1,637,015
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants non-collateralized COVID-19 written-off expected to be material.
Concentrations of Credit Risk and Other Concentrations	Concentrations of Credit Risk and Other Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of June 30, 2021 and December 31, 2020 were $243.0 million and $156.9 million, respectively. Customer I represented 24% of total accounts receivable as of June 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of June 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of June 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable. For the three and six months ended June 30, 2021, no customer represented more than 10% of total revenue. For the three and six months ended June 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue and Customer A, which is in the commercial operating segment, represented 10% of total revenue, respectively. No other customer represented more than 10% of total revenue for the three and six months ended June 30, 2020. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service functions of its business.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements I 2019-12, Simplifying the Accounting for Income Taxes (Topic 740) as part of its simplification initiative to reduce the cost and complexity in accounting for income taxes. ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also amends other aspects of the guidance to help simplify and promote consistent application of GAAP. The Company adopted ASU 2019-12 as of January 1, 2021 using transition methods allowed under each aspect of the guidance. The adoption of the standard did not have a material impact on the Company’s condensed consolidated financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of June 30, 2021 2020 Cash and cash equivalents $ 2,341,156 $ 1,497,591 Restricted cash 36,750 37,069 Restricted cash, noncurrent 61,914 102,355 Total cash, cash equivalents, and restricted cash $ 2,439,820 $ 1,637,015

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis	The following tables present the Company’s assets that are measured at fair value on a recurring and nonrecurring basis and indicates the fair value hierarchy of the valuation (in thousands): As of June 30, 2021 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 963,873 $ 963,873 $ — $ — Certificates of deposit 65,477 — 65,477 — Total $ 1,029,350 $ 963,873 $ 65,477 $ — As of December 31, 2020 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 1,075,783 $ 1,075,783 $ — $ — Certificates of deposit 74,097 — 74,097 — Total $ 1,149,880 $ 1,075,783 $ 74,097 $ —

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jun. 30, 2021
Balance Sheet Related Disclosures [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of June 30, 2021 As of December 31, Leasehold improvements $ 81,057 $ 85,196 Computer equipment, software, and other 23,199 22,275 Furniture and fixtures 10,069 9,976 Construction in progress 442 493 Total property and equipment, gross 114,767 117,940 Less: accumulated depreciation and amortization (89,943) (88,399) Total property and equipment, net $ 24,824 $ 29,541
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): As of June 30, As of December 31, Accrued payroll and related expenses $ 95,574 $ 85,466 Accrued other liabilities 70,678 73,080 Total accrued liabilitie s $ 166,252 $ 158,546

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2021
Investment Commitments [Abstract]
Summary of Investment commitments	The following table presents details related to the Company’s investment commitments as of June 30, 2021 (in thousands): Entity Investment Committed Committed Lilium March 30, 2021 4,100 $ 41,000 Sarcos Robotics (1) April 5, 2021 2,100 21,000 Roivant Sciences May 1, 2021 3,000 30,000 Celularity (1)(2) May 5, 2021 2,000 20,000 Mobility company May 11, 2021 2,000 20,000 Wejo May 28, 2021 3,500 35,000 Babylon Health (1) June 3, 2021 3,500 35,000 Boxed (1) June 13, 2021 2,000 20,000 Pear Therapeutics June 21, 2021 1,000 10,000 Autonomous vehicle company (1) June 22, 2021 1,800 18,000 Total 25,000 $ 250,000 (1) Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. (2) The Company’s investment closed during July 2021.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2021
Stockholders' Equity Note [Abstract]
Summary of Total Authorized, Issued, And Outstanding Shares	The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of June 30, 2021 As of December 31, 2020 Authorized Issued and Authorized Issued and Common stock: Class A 20,000,000 1,855,143 20,000,000 1,542,058 Class B 2,700,000 80,430 2,700,000 249,077 Class F 1,005 1,005 1,005 1,005 Total 22,701,005 1,936,578 22,701,005 1,792,140

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2021
Share-based Payment Arrangement [Abstract]
Summary of Stock Option Activity	The following table summarizes stock option activity for the six months ended June 30, 2021 (in thousands, except per share amounts): Options Weighted- Weighted- Remaining Aggregate Balance as of December 31, 2020 535,767 $ 6.12 7.99 $ 9,340,245 Options exercised (114,471 ) 3.29 Options canceled and forfeited (3,622 ) 5.17 Balance as of June 30, 2021 417,674 $ 6.90 8.49 $ 8,128,222 Options vested and exercisable as of June 30, 2021 213,423 $ 3.92 6.41 $ 4,788,520
Summary of RSU Activity	The following table summarizes the RSU activity for the six months ended June 30, 2021 (in thousands, except per share amounts): RSUs Weighted Average Unvested and outstanding as of December 31, 2020 184,870 $ 6.97 RSUs granted 10,131 27.25 RSUs vested (23,832 ) 8.41 RSUs canceled (4,447 ) 7.21 Unvested and outstanding as of June 30, 2021 166,722 $ 7.98
Summary of Stock-Based Compensation Expense	Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Cost of revenue $ 24,029 $ 17,832 $ 40,006 $ 25,900 Sales and marketing 72,008 39,932 129,294 58,395 Research and development 50,630 37,897 88,504 52,929 General and administrative 86,075 32,187 168,669 44,731 Total stock-based compensation expense $ $ $ $

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Summary of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended Six Months Ended 2021 2020 2021 2020 Numerator Net loss attributable to common stockholders $ (138,580 ) $ (110,455 ) $ (262,054 ) $ (164,729 ) Less: Change in fair value attributable to participating securities — (171 ) — (7,479 ) Net loss attributable to common stockholders, for diluted net loss per share $ (138,580 ) $ (110,626 ) $ (262,054 ) $ (172,208 ) Denominator Weighted-average shares used in computing net loss per share, basic 1,894,606 640,450 1,858,085 616,150 Weighted-average shares used in computing net loss per share, diluted 1,894,606 640,669 1,858,085 618,635 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.07 ) $ (0.17 ) $ (0.14 ) $ (0.27 ) Net loss per share attributable to common stockholders, diluted $ (0.07 ) $ (0.17 ) $ (0.14 ) $ (0.28 )
Summary of Antidilutive Securities	The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Redeemable convertible preferred stock — 4,017 — 4,017 Convertible preferred stock — 791,346 — 791,346 Warrants to purchase redeemable convertible and convertible preferred — 20,839 — 18,253 Warrants to purchase common stock 13,042 — 13,042 — Options and SARs issued and outstanding 417,699 459,239 417,699 459,239 RSUs outstanding 166,722 178,685 166,722 178,685 Growth units outstanding — 3,583 — 3,583 Total 597,463 1,457,709 597,463 1,455,123

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	6 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Summary of Financial Information for Each Reportable Segment	Financial information for each reportable segment was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue: Government $ 232,119 $ 139,569 $ 440,539 $ 257,696 Commercial 143,523 112,320 276,337 223,520 Total revenue $ 375,642 $ 251,889 $ 716,876 $ 481,216 Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Contribution: Government $ 143,253 $ 80,327 $ 274,999 $ 132,224 Commercial 75,121 58,398 147,664 99,412 Total contribution $ 218,374 $ 138,725 $ 422,663 $ 231,636
Summary of Reconciliation of Segment Financial Information to Loss from Operations	The reconciliation of contribution to loss from operations is as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Loss from operations $ (146,148 ) $ (99,145 ) $ (260,162 ) $ (169,330 ) Research and development expenses (1) 59,894 48,918 120,491 99,686 General and administrative expenses (1) 71,886 61,104 135,861 119,325 Stock-based compensation expense 232,742 127,848 426,473 181,955 Total contribution $ 218,374 $ 138,725 $ 422,663 $ 231,636 ————— (1)
Summary of Revenue by Geography	Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended June 30, 2021 2020 Amount % Amount % Revenue: United States $ 199,930 53 % 124,993 50 % United Kingdom 39,935 11 % 30,033 12 % France 19,088 5 % 29,629 12 % Rest of world (1) 116,689 31 % 67,234 26 % Total revenue $ 375,642 % 251,889 100 % (1) 10 % or more of total revenue for the three months ended June 30, 2021 or 2020. Six Months Ended June 30, 2021 2020 Amount % Amount % Revenue: United States $ 398,377 56% $ 234,770 49% United Kingdom 74,320 10% 59,008 12% France 40,178 6% 55,359 12% Rest of world (1) 204,001 28% 132,079 27% Total revenue $ 716,876 100% $ 481,216 100% (1)

Subsequent Events (Tables)

Subsequent Events (Tables)	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Summary of Additional Investment Commitments	The following table presents details regarding such additional investment commitments outstanding as of the date of this filing (in thousands): Entity Investment Agreement Committed Committed Fast Radius (1) July 18, 2021 2,000 $ 20,000 Tritium (1) July 27, 2021 1,500 15,000 AdTheorent (1) July 27, 2021 1,500 15,000 FinAccel August 2, 2021 1,000 10,000 Total 6,000 $ 60,000 (1) onvenience .
Summary of Investment Commitments	Additionally, during July 1, 2021 through the date of this filing, the Company purchased million shares for an aggregate purchase price of $ million, as set forth in the following table (in thousands): Entity Share Amount Investment Amount Celularity (1) 2,000 $ 20,000 Electric vehicle company 2,500 25,000 Autonomous aerial vehicle company 3,000 3,000 Astrocast 1,518 5,000 Total 9,018 $ 53,000 (1) Footnote 8. Commitments and Contingencies .

Significant Accounting Polici_4

Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Cash and cash equivalents	$ 2,341,156	$ 2,011,323	$ 1,497,591
Restricted cash	36,750	37,285	37,069
Restricted cash, noncurrent	61,914	79,538	102,355
Total cash, cash equivalents, and restricted cash	$ 2,439,820	$ 2,128,146	$ 1,637,015	$ 1,401,962

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Accounts receivable	$ 242,998,000		$ 242,998,000		$ 156,932,000
Allowance for doubtful accounts on trade receivables	$ 0		$ 0		$ 0
Accounts Receivable [Member] | Customer I [Member]
Percentage Concentration			24.00%
Accounts Receivable [Member] | Customer G [Member]
Percentage Concentration					13.00%
Revenue Benchmark [Member] | Customer A [Member]
Percentage Concentration		10.00%		10.00%
Revenue Benchmark [Member] | Customer F [Member]
Percentage Concentration		11.00%		11.00%
Minimum [Member] | Revenue Benchmark [Member]
Percentage Concentration	10.00%	10.00%	10.00%	10.00%
Maximum [Member] | Accounts Receivable [Member]
Percentage Concentration			10.00%		10.00%
Maximum [Member] | Revenue Benchmark [Member]
Percentage Concentration	0.00%	0.00%	0.00%	0.00%

Contract Liabilities and Rema_2

Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Performance obligation	$ 671.9
Performance obligation percentage to be recognised as revenue in the next twelve months	49.00%
Contract with customer, liability	$ 555.5		$ 531.9
Revenue recognized from contract liability balances	$ 285.4	$ 301.3

Fair Value Measurements - Summa

Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 1,029,350	$ 1,149,880
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	963,873	1,075,783
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	65,477	74,097
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	0	0
Restricted Cash [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Certificates of deposit	65,477	74,097
Restricted Cash [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Certificates of deposit	0	0
Restricted Cash [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Certificates of deposit	65,477	74,097
Restricted Cash [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Certificates of deposit	0	0
Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	963,873	1,075,783
Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	963,873	1,075,783
Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 0	$ 0

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Total property and equipment, gross	$ 114,767	$ 117,940
Less: accumulated depreciation and amortization	(89,943)	(88,399)
Total property and equipment, net	24,824	29,541
Leasehold improvements [Member]
Total property and equipment, gross	81,057	85,196
Computer equipment, software, and other [Member]
Total property and equipment, gross	23,199	22,275
Furniture and fixtures [Member]
Total property and equipment, gross	10,069	9,976
Construction in progress [Member]
Total property and equipment, gross	$ 442	$ 493

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Accrued payroll and related expenses	$ 95,574	$ 85,466
Accrued other liabilities	70,678	73,080
Total accrued liabilities	$ 166,252	$ 158,546

Balance Sheet Components - Addi

Balance Sheet Components - Additional information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Depreciation and amortisation expense excluding the impact of foreign exchange fluctuations	$ 3.1	$ 3.2	$ 6.3	$ 6.8

Equity Method Investments - Add

Equity Method Investments - Additional information (Detail) $ in Millions	1 Months Ended
	Nov. 30, 2019USD ($)shares
Palantir Technologies Japan, K.K. [Member]
Schedule of Equity Method Investments [Line Items]
Number of shares purchased | shares	100,000
Payments made to acquire equity method investments | $	$ 25
Equity method investment ownership percentage	50.00%
SOMPO [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment ownership percentage	50.00%

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Millions	Apr. 01, 2021	Oct. 30, 2014	Jun. 30, 2021
2014 Revolving Credit Facility [Member]
Long-term Debt [Line Items]
Line of credit facility variable interest rate description			London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75%
Line of credit facility commitment fee percentage		0.375%
Line of credit maturity date			Jun. 4, 2023
Debt instrument carrying amount			$ 0
Debt Instrument, periodic payment, principal	$ 200
2014 Revolving Credit Facility [Member] | Incremental Credit Facility [Member]
Long-term Debt [Line Items]
Undrawn revolving credit facility amount			400
Increase in borrowing capacity	200
2014 Revolving Credit Facility [Member] | Minimum [Member]
Long-term Debt [Line Items]
Line of credit minimum liquidity to be maintained			$ 50
2014 Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Long-term Debt [Line Items]
Line of credit facility variable interest rate spread			2.75%
Line of credit facility variable interest rate description		London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75%
Amended 2014 Revolving Credit Facility [Member]
Long-term Debt [Line Items]
Debt instrument maximum borrowing capacity	400
Amended 2014 Revolving Credit Facility [Member] | Term Loan [Member] | Incremental Credit Facility [Member]
Long-term Debt [Line Items]
Undrawn revolving credit facility amount	$ 100

Commitments and Contingencies

Commitments and Contingencies - Summary of Investment commitments (Detail) shares in Thousands, $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)shares
Commitments and Contingencies [Line Items]
Number of shares committed to purchase | shares	25,000
Purchase Price Commitment | $	$ 250,000
Lilium [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Mar. 30, 2021
Number of shares committed to purchase | shares	4,100
Purchase Price Commitment | $	$ 41,000
Sarcos Robotics [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Apr. 5, 2021	[1]
Number of shares committed to purchase | shares	2,100	[1]
Purchase Price Commitment | $	$ 21,000	[1]
Roivant Sciences [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	May 1, 2021
Number of shares committed to purchase | shares	3,000
Purchase Price Commitment | $	$ 30,000
Celularity [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	May 5, 2021	[1],[2]
Number of shares committed to purchase | shares	2,000	[1],[2]
Purchase Price Commitment | $	$ 20,000	[1],[2]
Mobility Company [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	May 11, 2021
Number of shares committed to purchase | shares	2,000
Purchase Price Commitment | $	$ 20,000
Wejo [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	May 28, 2021
Number of shares committed to purchase | shares	3,500
Purchase Price Commitment | $	$ 35,000
Babylon Health [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 3, 2021	[1]
Number of shares committed to purchase | shares	3,500	[1]
Purchase Price Commitment | $	$ 35,000	[1]
Boxed [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 13, 2021	[1]
Number of shares committed to purchase | shares	2,000	[1]
Purchase Price Commitment | $	$ 20,000	[1]
Pear Therapeutics [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 21, 2021
Number of shares committed to purchase | shares	1,000
Purchase Price Commitment | $	$ 10,000
Autonomous Vehicle Company [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 22, 2021	[1]
Number of shares committed to purchase | shares	1,800	[1]
Purchase Price Commitment | $	$ 18,000	[1]
[1]	Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.
[2]	The Company’s investment closed during July 2021.

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2020	Dec. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Loss Contingencies [Line Items]
Letter of credit outstanding amount			$ 98,700		$ 98,700		$ 116,800
Purchase Price Commitment					$ 250,000
Number of shares committed to purchase					25,000
Revenue from Committed Investments			$ 375,642	$ 251,889	$ 716,876	$ 481,216
Investment Agreement [Member]
Loss Contingencies [Line Items]
Enterprise subscription contract term			3 years
Registration Payment Arrangement, Term					10 years
Investment Agreement [Member] | Contractual Options [Member]
Loss Contingencies [Line Items]
Registration Payment Arrangement, Maximum Potential Consideration			$ 73,000		$ 73,000
Investment Agreement [Member] | Maximum [Member] | Commercial Contract [Member]
Loss Contingencies [Line Items]
Registration Payment Arrangement, Maximum Potential Consideration			428,000		428,000
Investment Commitments [Member]
Loss Contingencies [Line Items]
Revenue from Committed Investments			3,000		3,000
Investment Commitments [Member] | Investment Agreement [Member]
Loss Contingencies [Line Items]
Purchase Price Commitment			$ 250,000
Number of shares committed to purchase			25,000
Purchase Commitment One [Member]
Loss Contingencies [Line Items]
Minimum annual commitment		$ 1,490,000
Long-term Purchase Commitment, Description		If the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract.
Purchase Commitment For Contract Year One					126,000
Purchase Commitment For Contract Year two					167,000
Purchase Commitment Two [Member]
Loss Contingencies [Line Items]
Minimum annual commitment	$ 45,000
Satisfied purchase commitment					$ 6,000

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) - shares	Jun. 30, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Common stock, shares authorized	22,701,005,000	22,701,005,000
Common stock, shares issued	1,936,578,000	1,792,140,000
Common stock, shares outstanding	1,936,578,000	1,792,140,000
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized	20,000,000,000	20,000,000,000
Common stock, shares issued	1,855,143,000	1,542,058,000
Common stock, shares outstanding	1,855,143,000	1,542,058,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock, shares authorized	2,700,000,000	2,700,000,000
Common stock, shares issued	80,430,000	249,077,000
Common stock, shares outstanding	80,430,000	249,077,000
Common Class F [Member]
Class of Stock [Line Items]
Common stock, shares authorized	1,005,000	1,005,000
Common stock, shares issued	1,005,000	1,005,000
Common stock, shares outstanding	1,005,000	1,005,000

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2021
Minimum ownership threshold		100,000,000
Dividends declared		$ 0
Common Class B [Member]
Number of shares exchanged	1,005,000
Common Class F [Member]
Voting power		50.00%
Redeemable Convertible Preferred Stock [Member] | Common Class B [Member]
Number of shares issued for conversion	4,017,378
Convertible preferred stock [Member] | Common Class B [Member]
Number of shares issued for conversion	793,725,807

Stock-Based Compensation - Add

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Common shares issuable upon full vesting of the growth units	1,500,000
Unrecognized share based compensation expense		$ 1,000,000
Unrecognized share based compensation expense, period for recognition		8 years 25 days
Stock-based compensation		$ 426,473	$ 181,955
Restricted Stock Units (RSUs) [Member]
Unrecognized share based compensation expense		$ 815,000
Unrecognized share based compensation expense, period for recognition		3 years 2 months 12 days
Outstanding growth unit vested		166,722,000		184,870,000
Growth units [Member]
Stock-based compensation	$ 1,200
Outstanding growth unit vested	3,600,000

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Option Activity (Detail) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares
Share-based Payment Arrangement [Abstract]
Beginning Balance of Options Outstanding | shares	535,767,000
Options exercised | shares	(114,471,000)
Options canceled and forfeited | shares	(3,622,000)
Ending Balance of Options Outstanding | shares	417,674,000	535,767,000
Options vested and exercisable as of June 30, 2021 | shares	213,423,000
Beginning Balance of Weighted-Average Exercise Price Per Share | $ / shares	$ 6.12
Options exercised | $ / shares	3.29
Options canceled and forfeited | $ / shares	5.17
Ending Balance of Weighted-Average Exercise Price Per Share | $ / shares	6.90	$ 6.12
Options vested and exercisable as of June 30, 2021 | $ / shares	$ 3.92
Weighted- Average Remaining Contractual Life (years)	8 years 5 months 26 days	7 years 11 months 26 days
Options vested and exercisable as of June 30, 2021	6 years 4 months 28 days
Aggregate Intrinsic Value | $	$ 8,128,222	$ 9,340,245
Options vested and exercisable as of June 30, 2021 | $	$ 4,788,520

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of RSU Activity (Detail) - Restricted Stock Units	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested and Outstanding Beginning Balance | shares	184,870,000
RSUs granted | shares	10,131,000
RSUs vested | shares	(23,832,000)
RSUs canceled | shares	(4,447,000)
Unvested and Outstanding Ending Balance | shares	166,722,000
Weighted Average Grant Date Fair Value per Share Beginning Balance | $ / shares	$ 6.97
RSUs granted | $ / shares	27.25
RSUs vested | $ / shares	8.41
RSUs canceled | $ / shares	7.21
Weighted Average Grant Date Fair Value per Share Ending Balance | $ / shares	$ 7.98

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 232,742	$ 127,848	$ 426,473	$ 181,955
Cost of revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	24,029	17,832	40,006	25,900
Sales and marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	72,008	39,932	129,294	58,395
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	50,630	37,897	88,504	52,929
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 86,075	$ 32,187	$ 168,669	$ 44,731

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Provision (benefit) for income taxes	$ (5,661)	$ 943	$ (2,559)	$ 3,500
Minimum [Member]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	19.00%
Maximum [Member]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	25.00%

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Numerator
Net loss attributable to common stockholders	$ (138,580)	$ (110,455)	$ (262,054)	$ (164,729)
Less: Change in fair value attributable to participating securities		(171)		(7,479)
Net loss attributable to common stockholders, for diluted net loss per share	$ (138,580)	$ (110,626)	$ (262,054)	$ (172,208)
Denominator
Weighted-average shares used in computing net loss per share, basic	1,894,606	640,450	1,858,085	616,150
Weighted-average shares used in computing net loss per share, diluted	1,894,606	640,669	1,858,085	618,635
Net loss per share
Net loss per share attributable to common stockholders, basic	$ (0.07)	$ (0.17)	$ (0.14)	$ (0.27)
Net loss per share attributable to common stockholders, diluted	$ (0.07)	$ (0.17)	$ (0.14)	$ (0.28)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	597,463	1,457,709	597,463	1,455,123
Redeemable Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		4,017		4,017
Convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		791,346		791,346
Warrants to purchase redeemable convertible and convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		20,839		18,253
Warrants to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	13,042		13,042
Options and SARs issued and outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	417,699	459,239	417,699	459,239
RSUs outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	166,722	178,685	166,722	178,685
Growth units outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		3,583		3,583

Segment and Geographic Inform_3

Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - Operating Segments [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Information [Line Items]
Revenues	$ 375,642	$ 251,889	$ 716,876	$ 481,216
Contribution	218,374	138,725	422,663	231,636
Government [Member]
Segment Reporting Information [Line Items]
Revenues	232,119	139,569	440,539	257,696
Contribution	143,253	80,327	274,999	132,224
Commercial [Member]
Segment Reporting Information [Line Items]
Revenues	143,523	112,320	276,337	223,520
Contribution	$ 75,121	$ 58,398	$ 147,664	$ 99,412

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Information [Line Items]
Loss from operations		$ (146,148)	$ (99,145)	$ (260,162)	$ (169,330)
Stock-based compensation expense		232,742	127,848	426,473	181,955
Reconciling items
Segment Reporting Information [Line Items]
Research and development expenses	[1]	59,894	48,918	120,491	99,686
General and administrative expenses	[1]	71,886	61,104	135,861	119,325
Stock-based compensation expense		232,742	127,848	426,473	181,955
Operating Segments
Segment Reporting Information [Line Items]
Contribution		$ 218,374	$ 138,725	$ 422,663	$ 231,636
[1]	Excludes stock-based compensation expense.

Segment and Geographic Inform_5

Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2021		Jun. 30, 2020		Jun. 30, 2021		Jun. 30, 2020
Disaggregation of Revenue [Line Items]
Revenues	$ 375,642		$ 251,889		$ 716,876		$ 481,216
Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 375,642		$ 251,889		$ 716,876		$ 481,216
Concentration risk, percentage	100.00%		100.00%		100.00%		100.00%
United States [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 199,930		$ 124,993		$ 398,377		$ 234,770
Concentration risk, percentage	53.00%		50.00%		56.00%		49.00%
United Kingdom [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 39,935		$ 30,033		$ 74,320		$ 59,008
Concentration risk, percentage	11.00%		12.00%		10.00%		12.00%
France [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 19,088		$ 29,629		$ 40,178		$ 55,359
Concentration risk, percentage	5.00%		12.00%		6.00%		12.00%
Rest of world [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 116,689	[1]	$ 67,234	[1]	$ 204,001	[2]	$ 132,079	[2]
Concentration risk, percentage	31.00%	[1]	26.00%	[1]	28.00%	[2]	27.00%	[2]
[1]	No other country represents 10% or more of total revenue for the three months ended June 30, 2021 or 2020.
[2]	No other country represents 10% or more of total revenue for the six months ended June 30, 2021 or 2020.

Segment and Geographic Inform_6

Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue Benchmark [Member] | Minimum [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	10.00%	10.00%	10.00%	10.00%

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Subsequent Event [Member] shares in Millions, $ in Millions	Aug. 31, 2021USD ($)ozshares	Jul. 01, 2021USD ($)shares
Equity Investment [Member]
Subsequent Event [Line Items]
Number of additional shares committed to purchase | shares		6
Additional purchase price commitment		$ 60
Number of shares purchased	$ 50.7
Payments made to acquire equity method investments | oz	100
Additional Investment Agreement [Member]
Subsequent Event [Line Items]
Number of shares purchased | shares	9	9
Aggregate purchase price	$ 53	$ 53
Registration payment arrangement, term		six years
Additional Investment Agreement [Member] | Commercial Contract [Member] | Maximum [Member]
Subsequent Event [Line Items]
Registration Payment Arrangement, Maximum Potential Consideration		$ 162

Subsequent Events - Summary of

Subsequent Events - Summary of Additional Investment Commitments (Detail) - Additional Investment Commitment [Member] shares in Thousands, $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)shares
Investment Holdings Schedule Of Additional Investments [Line Items]
Committed share amount | shares	6,000
Committed investment amount | $	$ 60,000
Fast Radius [Member]
Investment Holdings Schedule Of Additional Investments [Line Items]
Investment Agreement Date	Jul. 18, 2021	[1]
Committed share amount | shares	2,000	[1]
Committed investment amount | $	$ 20,000	[1]
Tritium [Member]
Investment Holdings Schedule Of Additional Investments [Line Items]
Investment Agreement Date	Jul. 27, 2021	[1]
Committed share amount | shares	1,500	[1]
Committed investment amount | $	$ 15,000	[1]
AdTheorent [Member]
Investment Holdings Schedule Of Additional Investments [Line Items]
Investment Agreement Date	Jul. 27, 2021	[1]
Committed share amount | shares	1,500	[1]
Committed investment amount | $	$ 15,000	[1]
FinAccel [Member]
Investment Holdings Schedule Of Additional Investments [Line Items]
Investment Agreement Date	Aug. 2, 2021
Committed share amount | shares	1,000
Committed investment amount | $	$ 10,000
[1]	Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.

Subsequent Event - Summary of I

Subsequent Event - Summary of Investment Commitments (Detail) - USD ($) shares in Thousands, $ in Thousands		Jul. 01, 2021	Jun. 30, 2021
Subsidiary or Equity Method Investee [Line Items]
Number of shares committed to purchase			25,000
Purchase Price Commitment			$ 250,000
Subsequent Event [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares committed to purchase		9,018
Purchase Price Commitment		$ 53,000
Celularity [Member] | Subsequent Event [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares committed to purchase	[1]	2,000
Investment Amount	[1]	$ 20,000
Electric Vehicle Company [Member] | Subsequent Event [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares committed to purchase		2,500
Purchase Price Commitment		$ 25,000
Autonomous Aerial Vehicle Company [Member] | Subsequent Event [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares committed to purchase		3,000
Purchase Price Commitment		$ 3,000
Astrocast [Member] | Subsequent Event [Member]
Subsidiary or Equity Method Investee [Line Items]
Number of shares committed to purchase		1,518
Investment Amount		$ 5,000
[1]	Reflected as commitment in Footnote 8. Commitments and Contingencies as of June 30, 2021.